Cataract and Glaucoma Services, Sankara Eye Hospital, Coimbatore, Tamil Nadu, India.
Indian J Ophthalmol. 2022 Mar;70(3):801-806. doi: 10.4103/ijo.IJO_1650_21.
To compare the postoperative uncorrected distance visual acuity (UDVA) and refractive outcomes of cataract patients with astigmatism following implantation of Eyecryl and Tecnis® toric intraocular lenses (IOLs).
We conducted a single-center, retrospective study including patients who had undergone phacoemulsification and implantation with either Eyecryl toric (Group 1) or Tecnis® toric (Group 2) IOL. The primary outcome measures included postoperative UDVA and residual astigmatism at 3 months. The secondary outcome measure was IOL misalignment >10° throughout the follow-up period.
One hundred and eight eyes of 76 patients (44 males and 32 females) were analyzed. Twenty-nine patients (38 eyes) received Eyecryl toric IOL (Group 1), and 47 patients (70 eyes) received Tecnis® toric IOL (Group 2). Groups 1 and 2 showed a mean postoperative logMAR UDVA of 0.09 ± 0.11 and 0.06 ± 0.09, respectively, at 3 months (P = 0.114). In both groups, all the eyes achieved a postoperative UDVA of ≤0.3 logMAR. The postoperative residual astigmatism of group 1 and group 2 was -0.29 ± 0.34 D and -0.16 ± 0.27 D, respectively (P = 0.038). Postoperative astigmatism was within ± 1.00 D in all the eyes. No eyes had an IOL misalignment >10° throughout the follow-up period.
Both Eyecryl and Tecnis® toric IOLs provided significant improvement in uncorrected visual acuity and astigmatism correction postoperatively. The Tecnis® toric IOL provided statistically significant lower residual astigmatism than Eyecryltoric IOL. However, the difference in postoperative astigmatism between the two IOLs was clinically insignificant.
比较白内障伴散光患者植入 Eyecryl 和 Tecnis® toric 人工晶状体(IOL)后的术后未矫正距离视力(UDVA)和屈光结果。
我们进行了一项单中心回顾性研究,纳入了接受超声乳化白内障吸除术并植入 Eyecryl 散光(第 1 组)或 Tecnis® toric 散光(第 2 组)IOL 的患者。主要观察指标包括术后 3 个月的 UDVA 和残余散光。次要观察指标是整个随访期间 IOL 偏位>10°。
共分析了 76 例患者(44 名男性和 32 名女性)的 108 只眼。29 例(38 只眼)接受 Eyecryl 散光 IOL(第 1 组),47 例(70 只眼)接受 Tecnis® toric 散光 IOL(第 2 组)。第 1 组和第 2 组术后 3 个月时的平均 logMAR UDVA 分别为 0.09±0.11 和 0.06±0.09(P=0.114)。两组术后所有眼的 UDVA 均达到≤0.3 logMAR。第 1 组和第 2 组术后残余散光分别为-0.29±0.34 D 和-0.16±0.27 D(P=0.038)。所有眼的术后散光均在±1.00 D 以内。整个随访期间,无眼的 IOL 偏位>10°。
Eyecryl 和 Tecnis® toric 散光 IOL 均可显著改善术后未矫正视力和散光矫正。Tecnis® toric IOL 术后残余散光明显低于 Eyecryltoric IOL。然而,两种 IOL 术后散光的差异在临床上无显著意义。